Lundbeck eyes acquisition of Xeris Biopharma
Lundbeck has expressed interest in acquiring Xeris Biopharma, a commercial-stage drugmaker, according to people familiar with the matter.
All AI Pulse updates tagged "biopharma".
1 signalsLundbeck has expressed interest in acquiring Xeris Biopharma, a commercial-stage drugmaker, according to people familiar with the matter.